Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Life Sciences research
Shield Therapeutics Plc
Life Sciences
Taking on China
By
Dr Dorothea Hill
14 Jan 2020
Advanced Oncotherapy
Life Sciences
Proving the accuracy and superiority of minibeams
By
Dr Gregoire Pave
04 Dec 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Diurnal Group Plc
Life Sciences
Successful DITEST Phase I trial outcome
By
Dr Gregoire Pave
26 Nov 2019
genedrive Plc
Life Sciences
Regulatory hurdle leaped: hearing loss assay
By
Dr Dorothea Hill
21 Nov 2019
Incanthera Ltd
Life Sciences
Realising near-term value in oncology
By
Dr Gregoire Pave
20 Nov 2019
Advanced Oncotherapy
Life Sciences
FLASH benefits from new US reimbursement
By
Dr Dorothea Hill
11 Nov 2019
Diurnal Group Plc
Life Sciences
Approaching a number of near-term milestones
By
Dr Gregoire Pave
05 Nov 2019
Shield Therapeutics Plc
Life Sciences
More choice for clinicians and patients
By
Dr Dorothea Hill
30 Oct 2019
genedrive Plc
Life Sciences
Acceleration of news flow expected
By
Dr Dorothea Hill
28 Oct 2019
Oxford BioMedica
Life Sciences
Demanding second half
By
Dr Dorothea Hill
16 Oct 2019
Allergy Therapeutics plc
Life Sciences
Continuing to gain market share
By
Dr Dorothea Hill
26 Sep 2019
Prev
1
2
3
4
5
6
...
17
Next
